Li Peifeng, Ma Jing, Zhang Xiumin, Guo Yong, Liu Yixiong, Li Xia, Zhao Danhui, Wang Zhe
State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, The Fourth Military Medical University, Changle West Road #169, Xi'an, 710032, Shaan Xi Province, China.
Diagn Pathol. 2018 May 22;13(1):31. doi: 10.1186/s13000-018-0709-9.
Small cell carcinoma of the uterine cervix is a rare and highly malignant tumor, and its etiopathogenesis is strongly related to high-risk HPV infections.
The clinicopathological data of 30 cases of cervical primary small cell carcinoma were retrospectively analyzed. In situ hybridization, polymerase chain reaction and reverse dot-blot hybridization were employed to detect HPV DNA in both small cell carcinoma and other coexisting epithelial tumors. Immunohistochemistry was used to detect the protein expression of p16 and p53.
Amongst 30 patients with cervical primary small cell carcinoma, 15 patients simultaneously exhibited other types of epithelial tumors, including squamous cell carcinoma, adenocarcinoma, squamous cell carcinoma in situ, and adenocarcinoma in situ. Most tumor cells infected with HPV presented integrated patterns in the nuclei by in situ hybridization. HPV DNA was detected in every small cell carcinoma case (100%) by polymerase chain reaction and reverse dot blot hybridization. 27 cases (90%) harbored type 18, and 15 (50%) displayed multiple HPV18 and 16 infections. The prevalence of HPV 18 infection in small cell carcinoma was higher than in cervical squamous and glandular epithelial neoplasms (P = 0.002). However, similar infection rates of HPV 16 were detected in both tumors (P = 0.383). Both small cell carcinoma and other types of epithelial tumors exhibited strong nuclear and cytoplasmic staining for p16 in all cases. Three cases of small cell carcinoma revealed completely negative p53 immunohistochemical expression in 15 cases of composite tumors, which suggested TP53 nonsense mutation pattern. The pure small cell carcinoma of uterine cervix had similar mutation or wild type pattern for TP53 compared with composite tumor (P = 0.224).
Cervical small cell carcinomas are often associated with squamous or glandular epithelial tumors, which might result from multiple HPV infections, especially HPV 16 infection. Multiple HPV infections were not correlated with tumor stage, size, lymphovascular invasion, lymph node metastasis, or prognosis. Furthermore, careful observation of specimens is very important in finding little proportion of small cell carcinoma in the composite lesions, specifically in cervical biopsy specimens, in order to avoid the missed diagnosis of small cell carcinoma.
宫颈小细胞癌是一种罕见的高恶性肿瘤,其发病机制与高危型人乳头瘤病毒(HPV)感染密切相关。
回顾性分析30例宫颈原发性小细胞癌的临床病理资料。采用原位杂交、聚合酶链反应和反向点杂交技术检测小细胞癌及同时存在的其他上皮性肿瘤中的HPV DNA。应用免疫组织化学方法检测p16和p53蛋白表达。
30例宫颈原发性小细胞癌患者中,15例同时合并其他类型上皮性肿瘤,包括鳞状细胞癌、腺癌、原位鳞状细胞癌和原位腺癌。原位杂交显示,大多数感染HPV的肿瘤细胞核呈整合型。聚合酶链反应和反向点杂交法在所有小细胞癌病例中均检测到HPV DNA(100%)。27例(90%)为18型,15例(50%)同时感染18型和16型HPV。小细胞癌中HPV 18型感染率高于宫颈鳞状上皮和腺上皮肿瘤(P = 0.002)。然而,两种肿瘤中HPV 16型感染率相似(P = 0.383)。所有病例中小细胞癌和其他类型上皮性肿瘤的p16均呈强核质染色。15例复合性肿瘤中有3例小细胞癌p53免疫组化表达完全阴性,提示TP53无义突变型。宫颈单纯性小细胞癌与复合性肿瘤的TP53突变型或野生型模式相似(P = 0.224)。
宫颈小细胞癌常与鳞状或腺上皮肿瘤相关,这可能是多种HPV感染所致,尤其是HPV 16型感染。多种HPV感染与肿瘤分期、大小、脉管浸润、淋巴结转移或预后无关。此外,仔细观察标本对于在复合病变中发现小比例的小细胞癌非常重要,特别是在宫颈活检标本中,以避免小细胞癌的漏诊。